Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases

Neuroscience and Biobehavioral Reviews

Volumn 74, Issue , 2017, Pages 321-329

  Tobaldini, Eleonora ^a,b   Costantino, Giorgio ^a   Solbiati, Monica ^a   Cogliati, Chiara ^c   Kara, Tomas ^d,e   Nobili, Lino ^f   Montano, Nicola ^a,b,g  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d HAMAD MEDICAL CORPORATION   (Qatar)

^e MAYO CLINIC   (United States)

^f OSPEDALE NIGUARDA CA GRANDA   (Italy)

^g ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Apnea; Autonomic nervous system; Cardiovascular diseases; Sleep deprivation

Indexed keywords

ATRIAL FIBRILLATION; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; HUMAN; HYPERTENSION; METABOLIC DISORDER; REVIEW; SLEEP; SLEEP DEPRIVATION; SLEEP DISORDER; RISK FACTOR; SLEEP DISORDERED BREATHING;

AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASES; HUMANS; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; SLEEP DEPRIVATION;

EID: 85002884704     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.07.004     Document Type: Review

References (105)

1. Ackermann, K., Plomp, R., Lao, O., Middleton, B., Revell, V.L., Skene, D.J., Kayser, M., Effect of sleep deprivation on rhythms of clock gene expression and melatonin in humans. Chronobiol. Int. 30:7 (2013), 901–909.
2. American Diabetes Association, Standards of medical care in diabetes—2010. Diabetes Care, 2010, S11–S61.
3. Aronsohn, R.S., Whitmore, H., Van Cauter, E., Tasali, E., Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am. J. Respir. Crit. Care Med. 181 (2010), 507–513.
4. Arzt, M., Hetzenecker, A., Steiner, S., Buchner, S., Sleep-disordered breathing and coronary artery disease. Can. J. Cardiol. 31 (2015), 909–917.
5. Babu, A.R., Herdegen, J., Fogelfeld, L., Shott, S., Mazzone, T., Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch. Intern. Med. 165:4 (2005), 447–452.
6. Bonnet, M.H., Arand, D.L., Hyperarousal and insomnia: state of the science. Sleep Med. Rev. 14 (2010), 9–15.
7. Bradley, T.D., Floras, J.S., Sleep apnea and heart failure: part II: central sleep apnea. Circulation 107:13 (2003), 1822–1826.
8. Bradley, T.D., Floras, J.S., Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 107:12 (2003), 1671–1678.
9. Bradley, T.D., Logan, A.G., Kimoff, R.J., Sériès, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., Hanly, P., Smilovitch, M., Tomlinson, G., Floras, J.S., CANPAP Investigators, Continuous positive airway pressure for central sleep apnea and heart failure. N. Engl. J. Med. 353:19 (2005), 2025–2033.
10. Brandenberger, G., Viola, A.U., Ehrhart, J., Charloux, A., Geny, B., Piquard, F., Simon, C., Age-related changes in cardiac autonomic control during sleep. J. Sleep Res. 12:3 (2003), 173–180.
11. Buysse, D.J., Angst, J., Gamma, A., Ajdacic, V., Eich, D., Rössler, W., Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 31:4 (2008), 473–480.
12. Calvin, A.D., Covassin, N., Kremers, W.K., Adachi, T., Macedo, P., Albuquerque, F.N., Bukartyk, J., Davison, D.E., Levine, J.A., Singh, P., Wang, S., Somers, V.K., Experimental sleep restriction causes endothelial dysfunction in healthy humans. J. Am. Heart Assoc., 3(6), 2014, e001143.
13. Caples, S.M., Somers, V.K., Sleep-disordered breathing and atrial fibrillation. Prog. Cardiovasc. Dis. 51:5 (2009), 411–415.
14. Cappuccio, F.P., D'Elia, L., Strazzullo, P., Miller, M.A., Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 33:5 (2010), 585–592.
15. Cowie, M.R., Woehrle, H., Wegscheider, K., Angermann, C., d'Ortho, M.P., Erdmann, E., Levy, P., Simonds, A.K., Somers, V.K., Zannad, F., Teschler, H., Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N. Engl. J. Med. 373:12 (2015), 1095–1105.
16. Dettoni, J.L., Consolim-Colombo, F.M., Drager, L.F., Rubira, M.C., Souza, S.B., Irigoyen, M.C., Mostarda, C., Borile, S., Krieger, E.M., Moreno, H. Jr., Lorenzi-Filho, G., Cardiovascular effects of partial sleep deprivation in healthy volunteers. J. Appl. Physiol. 113:2 (2012), 32–36.
17. Dewan, N.A., Nieto, F.J., Somers, V.K., Intermittent hypoxemia and OSA: implications for comorbidities. Chest 147:1 (2015), 266–274.
18. Dijk, D.J., Slow-wave sleep, diabetes, and the sympathetic nervous system. Proc. Natl. Acad. Sci. U. S. A. 105:4 (2008), 1107–1108.
19. Durán-Cantolla, J., Aizpuru, F., Miranda-Serrano, E., Rubio, R., Martínez-Null, C., de Miguel, J., Egea, C., Cancelo, L., Alvarez, A., Fernández-Bolaños, M., Barbé, F., Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the vitoria sleep cohort cano-pumarega I. Am. J. Respir. Crit. Care Med. 184:11 (2011), 1299–1304.
20. Fein, A.S., Shvilkin, A., Shah, D., Haffajee, C.I., Das, S., Kumar, K., Kramer, D.B., Zimetbaum, P.J., Buxton, A.E., Josephson, M.E., Anter, E., Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J. Am. Coll. Cardiol. 62:4 (2013), 300–305.
21. Floras, J.S., Hypertension and sleep apnea. Can. J. Cardiol. 31:7 (2015), 889–897.
22. Gami, A.S., Pressman, G., Caples, S.M., Kanagala, R., Gard, J.J., Davison, D.E., Malouf, J.F., Ammash, N.M., Friedman, P.A., Somers, V.K., Association of atrial fibrillation and obstructive sleep apnea. Circulation 110:4 (2004), 364–367.
23. Gami, A.S., Olson, E.J., Shen, W.K., Wright, R.S., Ballman, K.V., Hodge, D.O., Herges, R.M., Howard, D.E., Somers, V.K., Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J. Am. Coll. Cardiol. 62:7 (2013), 610–616.
24. Giles, T.L., Lasserson, T.J., Smith, B.H., White, J., Wright, J., Cates, C.J., Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst. Rev., 2006, CD001106.
25. Gottlieb, D.J., Punjabi, N.M., Newman, A.B., Resnick, H.E., Redline, S., Baldwin, C.M., Nieto, F.J., Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch. Intern. Med. 165:8 (2005), 863–867.
26. Gottlieb, D.J., Yenokyan, G., Newman, A.B., O'Connor, G.T., Punjabi, N.M., Quan, S.F., Redline, S., Resnick, H.E., Tong, E.K., Diener-West, M., Shahar, E., Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 122:4 (2010), 352–360.
27. Grandner, M.A., Jackson, N.J., Pak, V.M., Gehrman, P.R., Sleep disturbance is associated with cardiovascular and metabolic disorders. J. Sleep Res. 21:4 (2012), 427–433.
28. Guzzetti, S., Magatelli, R., Borroni, E., Mezzetti, S., Heart rate variability in chronic heart failure. Auton. Neurosci. 90:1–2 (2001), 102–105.
29. Högl, B., Kiechl, S., Willeit, J., Saletu, M., Frauscher, B., Seppi, K., Müller, J., Rungger, G., Gasperi, A., Wenning, G., Poewe, W., Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology 64:11 (2005), 1920–1924.
30. Hamilton, G.S., Meredith, I.T., Walker, A.M., Solin, P., Obstructive sleep apnea leads to transient uncoupling of coronary blood flow and myocardial work in humans. Sleep 32:2 (2009), 263–270.
31. Hayes, D. Jr., Anstead, M.I., Ho, J., Phillips, B.A., Insomnia and chronic heart failure. Heart Fail. Rev. 14:3 (2009), 171–182.
32. Herrscher, T.E., Akre, H., Øverland, B., Sandvik, L., Westheim, A.S., High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J. Card. Fail. 17:5 (2011), 420–425.
33. Imeri, L., Opp, M.R., How (and why) the immune system makes us sleep. Nat. Rev. Neurosci. 10:3 (2009), 199–210.
34. Irwin, M.R., Wang, M., Ribeiro, D., Cho, H.J., Olmstead, R., Breen, E.C., Martinez-Maza, O., Cole, S., Sleep loss activates cellular inflammatory signaling. Biol. Psychiatry 64:6 (2008), 538–540.
35. Javaheri, S., Blackwell, T., Ancoli-Israel, S., Ensrud, K.E., Stone, K.L., Redline, S., Osteoporotic Fractures in Men Study (MrOS) Research Group, Sleep disordered Breathing and incident heart failure in older men. Am. J. Respir. Crit. Care Med. 193:5 (2016), 561–568.
36. Kasai, T., Floras, J.S., Bradley, T.D., Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation 126:12 (2012), 1495–1510.
37. Kato, M., Phillips, B.G., Sigurdsson, G., Narkiewicz, K., Pesek, C.A., Somers, V.K., Effects of sleep deprivation on neural circulatory control. Hypertension 35:5 (2000), 1173–1175.
38. Kendzerska, T., Mollayeva, T., Gershon, A.S., Leung, R.S., Hawker, G., Tomlinson, G., Untreated obstructive sleep apnea and the risk for serious long-term adverse outcomes: a systematic review. Sleep Med. Rev. 18:1 (2014), 49–59.
39. Kent, B.D., Grote, L., Ryan, S., Pépin, J.L., Bonsignore, M.R., Tkacova, R., Saaresranta, T., Verbraecken, J., Lévy, P., Hedner, J., McNicholas, W.T., ESADA collaborators, Diabetes mellitus prevalence and control in sleep-disordered breathing: the European sleep apnea cohort (ESADA) study. Chest 146:4 (2014), 982–990.
40. Khayat, R., Abraham, W., Patt, B., Brinkman, V., Wannemacher, J., Porter, K., Jarjoura, D., Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. J. Card. Fail. 18:7 (2012), 534–540.
41. Konecny, T., Kara, T., Somers, V.K., Obstructive sleep apnea and hypertension: an update. Hypertension 63:2 (2014), 203–209.
42. La Rovere, M.T., Pinna, G.D., Maestri, R., Robbi, E., Mortara, A., Fanfulla, F., Febo, O., Sleight, P., Clinical relevance of short-term day-time breathing disorders in chronic heart failure patients. Eur. J. Heart Fail. 9:9 (2007), 949–954.
43. Lanfranchi, P.A., Braghiroli, A., Bosimini, E., Mazzuero, G., Colombo, R., Donner, C.F., Giannuzzi, P., Prognostic value of nocturnal cheyne-stokes respiration in chronic heart failure. Circulation 99:11 (1999), 1435–1440.
44. Laugsand, L.E., Strand, L.B., Platou, C., Vatten, L.J., Janszky, I., Insomnia and the risk of incident heart failure: a population study. Eur. Heart J. 35:21 (2014), 1382–1393.
45. Lee, C.H., Khoo, S.M., Chan, M.Y., Wong, H.B., Low, A.F., Phua, Q.H., Richards, A.M., Tan, H.C., Yeo, T.C., Severe obstructive sleep apnea and outcomes following myocardial infarction. J. Clin. Sleep Med. 7:6 (2011), 616–621.
46. Legramante, J.M., Marciani, M.G., Placidi, F., Aquilani, S., Romigi, A., Tombini, M., Massaro, M., Galante, A., Iellamo, F., Sleep-related changes in baroreflex sensitivity and cardiovascular autonomic modulation. J. Hypertens. 21:8 (2003), 1555–1561.
47. Levy, D., Kenchaiah, S., Larson, M.G., Benjamin, E.J., Kupka, M.J., Ho, K.K., Murabito, J.M., Vasan, R.S., Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347:18 (2002), 1397–1402.
48. Li, L., Wang, Z.W., Li, J., Ge, X., Guo, L.Z., Wang, Y., Guo, W.H., Jiang, C.X., Ma, C.S., Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. Europace 16:9 (2014), 1309–1314.
49. Li, Y., Zhang, X., Winkelman, J.W., Redline, S., Hu, F.B., Stampfer, M., Ma, J., Gao, X., Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation 129:7 (2014), 737–746.
50. Li, Y., Vgontzas, A.N., Fernandez-Mendoza, J., Bixler, E.O., Sun, Y., Zhou, J., Ren, R., Li, T., Tang, X., Insomnia with physiological hyperarousal is associated with hypertension. Hypertension 65:3 (2015), 644–650.
51. Liu, L., Continuous positive airway pressure in patients with obstructive sleep apnea and resistant hypertension: a meta-analysis of randomized controlled trials. J. Clin. Hypertens. (Greenwich) 18:2 (2016), 153–158.
52. Mallon, L., Broman, J.E., Hetta, J., Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. J. Intern. Med. 251:3 (2002), 207–216.
53. Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., Galderisi, M., Grobbee, D.E., Jaarsma, T., Kirchhof, P., Kjeldsen, S.E., Laurent, S., Manolis, A.J., Nilsson, P.M., Ruilope, L.M., Schmieder, R.E., Sirnes, P.A., Sleight, P., Viigimaa, M., Waeber, B., Zannad, F., Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and the European Society of Cardiology, 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press. 23:1 (2014), 3–16.
54. Mansfield, D.R., Gollogly, N.C., Kaye, D.M., Richardson, M., Bergin, P., Naughton, M.T., Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am. J. Respir. Crit. Care Med. 169:3 (2004), 361–366.
55. Marin, J.M., Carrizo, S.J., Vicente, E., Agusti, A.G., Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:9464 (2005), 1046–1053.
56. Marin, J.M., Agusti, A., Villar, I., Forner, M., Nieto, D., Carrizo, S.J., Barbé, F., Vicente, E., Wei, Y., Nieto, F.J., Jelic, S., Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 307:20 (2012), 2169–2176.
57. Mehra, R., Redline, S., Arrhythmia risk associated with sleep disordered breathing in chronic heart failure. Curr. Heart Fail. Rep. 11:1 (2014), 88–97.
58. Meier-Ewert, H.K., Ridker, P.M., Rifai, N., Regan, M.M., Price, N.J., Dinges, D.F., Mullington, J.M., Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J. Am. Coll. Cardiol. 43:4 (2004), 678–683.
59. Montano, N., Porta, A., Cogliati, C., Costantino, G., Tobaldini, E., Casali, K.R., Iellamo, F., Heart rate variability explored in the frequency domain: a tool to investigate the link between heart and behavior. Neurosci. Biobehav. Rev. 33:2 (2009), 71–80.
60. Muenter, N.K., Watenpaugh, D.E., Wasmund, W.L., Wasmund, S.L., Maxwell, S.A., Smith, M.L., Effect of sleep restriction on orthostatic cardiovascular control in humans. J. Appl. Physiol. 88:3 (2000), 966–972.
61. Murphy, M.J., Peterson, M.J., Sleep disturbances in depression. Sleep Med. Clin. 10:1 (2015), 17–23.
62. Nakashima, H., Katayama, T., Takagi, C., Amenomori, K., Ishizaki, M., Honda, Y., Suzuki, S., Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur. Heart J. 27:19 (2006), 2317–2322.
63. Narkiewicz, K., Somers, V.K., The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J. Hypertens. 15:12 pt. 2 (1997), 1613–1619.
64. Narkiewicz, K., van de Borne, P.J., Montano, N., Dyken, M.E., Phillips, B.G., Somers, V.K., Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97:10 (1998), 943–945.
65. Narkiewicz, K., Montano, N., Cogliati, C., van de Borne, P.J., Dyken, M.E., Somers, V.K., Altered cardiovascular variability in obstructive sleep apnea. Circulation 98:11 (1998), 1071–1077.
66. Schoenborn, C.A., Adams, P.F., Health behaviors of adults: United States, 2005–2007. Vital Health Stat. 10:245 (2010), 1–132.
67. Ng, C.Y., Liu, T., Shehata, M., Stevens, S., Chugh, S.S., Wang, X., Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am. J. Cardiol. 108:1 (2011), 47–51.
68. Patel, S.R., Malhotra, A., Gao, X., Hu, F.B., Neuman, M.I., Fawzi, W.W., A prospective study of sleep duration and pneumonia risk in women. Sleep 35:1 (2012), 97–101.
69. Paton, J.F., Nalivaiko, E., Boscan, P., Pickering, A.E., Reflexly evoked coactivation of cardiac vagal and sympathetic motor outflows: observations and functional implications. Clin. Exp. Pharmacol. Physiol. 33:12 (2006), 1245–1250.
70. Pedrosa, R.P., Drager, L.F., Gonzaga, C.C., Sousa, M.G., de Paula, L.K., Amaro, A.C., Amodeo, C., Bortolotto, L.A., Krieger, E.M., Bradley, T.D., Lorenzi-Filho, G., Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 58:5 (2011), 811–817.
71. Peker, Y., Kraiczi, H., Hedner, J., Löth, S., Johansson, A., Bende, M., An independent association between obstructive sleep apnoea and coronary artery disease. Eur. Respir. J. 14:1 (1999), 179–184.
72. Pillai, V., Cheng, P., Kalmbach, D.A., Roehrs, T., Roth, T., Drake, C.L., Prevalence and predictors of prescription sleep-aid use among individuals with DSM-5 insomnia: the role of hyperarousal. Sleep, 2016 pii: sp-00534-15.
73. Punjabi, N.M., Shahar, E., Redline, S., Gottlieb, D.J., Givelber, R., Resnick, H.E., Sleep Heart Health Study Investigators, Sleep-disordered breathing, glucose intolerance, and insulin resistance: the sleep heart health study. Am. J. Epidemiol. 160:6 (2004), 521–530.
74. Qureshi, W.T., Nasir, U.B., Alqalyoobi, S., O'Neal, W.T., Mawri, S., Sabbagh, S., Soliman, E.Z., Al-Mallah, M.H., Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea. Am. J. Cardiol. 116:11 (2015), 1767–1773.
75. Rafalson, L., Donahue, R.P., Stranges, S., Lamonte, M.J., Dmochowski, J., Dorn, J., Trevisan, M., Short sleep duration is associated with the development of impaired fasting glucose: the Western New York health study. Ann. Epidemiol. 20:12 (2010), 883–889.
76. Redline, S., Foody, J., Sleep disturbances: time to join the top 10 potentially modifiable cardiovascular risk factors?. Circulation 124:19 (2011), 2049–2051.
77. Reichmuth, K.J., Austin, D., Skatrud, J.B., Young, T., Association of sleep apnea and type II diabetes: a population-based study. Am. J. Respir. Crit. Care Med. 172:12 (2005), 1590–1595.
78. Romero-Corral, A., Somers, V.K., Pellikka, P.A., Olson, E.J., Bailey, K.R., Korinek, J., Orban, M., Sierra-Johnson, J., Kato, M., Amin, R.S., Lopez-Jimenez, F., Decreased right and left ventricular myocardial performance in obstructive sleep apnea. Chest 132:6 (2007), 1863–1870.
79. Saper, C.B., Scammell, T.E., Lu, J., Hypothalamic regulation of sleep and circadian rhythms. Nature 437:7063 (2005), 1257–1263.
80. Sauvet, F., Florence, G., Van Beers, P., Drogou, C., Lagrume, C., Chaumes, C., Ciret, S., Leftheriotis, G., Chennaoui, M., Total sleep deprivation alters endothelial function in rats: a nonsympathetic mechanism. Sleep 37:3 (2014), 465–473.
81. Sauvet, F., Drogou, C., Bougard, C., Arnal, P.J., Dispersyn, G., Bourrilhon, C., Rabat, A., Van Beers, P., Gomez-Merino, D., Faraut, B., Leger, D., Chennaoui, M., Vascular response to 1 week of sleep restriction in healthy subjects. A metabolic response?. Int. J. Cardiol. 190 (2015), 246–255.
82. Schulz, R., Blau, A., Börgel, J., Duchna, H.W., Fietze, I., Koper, I., Prenzel, R., Schädlich, S., Schmitt, J., Tasci, S., Andreas, S., working group Kreislauf und Schlaf of the German Sleep Society (DGSM), Sleep apnoea in heart failure. Eur. Respir. J. 29:6 (2007), 1201–1205.
83. Shamsuzzaman, A.S., Winnicki, M., Lanfranchi, P., Wolk, R., Kara, T., Accurso, V., Somers, V.K., Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:21 (2002), 2462–2464.
84. Somers, V.K., Dyken, M.E., Mark, A.L., Abboud, F.M., Sympathetic-nerve activity during sleep in normal subjects. N. Engl. J. Med. 328:5 (1993), 303–307.
85. Steiner, S., Schueller, P.O., Schulze, V., Strauer, B.E., Occurrence of coronary collateral vessels in patients with sleep apnea and total coronary occlusion. Chest 137:3 (2010), 516–520.
86. Stopford, E., Ravi, K., Nayar, V., The association of sleep disordered breathing with heart failure and other cardiovascular conditions. Cardiol. Res. Pract., 2013, 2013, 356280.
87. Sunbul, M., Kanar, B.G., Durmus, E., Kivrak, T., Sari, I., Acute sleep deprivation is associated with increased arterial stiffness in healthy young adults. Sleep Breath. 18:1 (2014), 215–220.
88. Takase, B., Akima, T., Satomura, K., Ohsuzu, F., Mastui, T., Ishihara, M., Kurita, A., Effects of chronic sleep deprivation on autonomic activity by examining heart rate variability, plasma catecholamine, and intracellular magnesium levels. Biomed. Pharmacother. 58 (2004), S35–S39.
89. Tasali, E., Leproult, R., Ehrmann, D.A., Van Cauter, E., Slow-wave sleep and the risk of type 2 diabetes in humans. Proc. Natl. Acad. Sci. U. S. A. 105:3 (2008), 1044–1049.
90. Tasali, E., Mokhlesi, B., Van Cauter, E., Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 133:2 (2008), 496–506.
91. Tobaldini, E., Nobili, L., Strada, S., Casali, K.R., Braghiroli, A., Montano, N., Heart rate variability in normal and pathological sleep. Front. Physiol., 4, 2013, 294.
92. Tobaldini, E., Cogliati, C., Fiorelli, E.M., Nunziata, V., Wu, M.A., Prado, M., Bevilacqua, M., Trabattoni, D., Porta, A., Montano, N., One night on-call: sleep deprivation affects cardiac autonomic control and inflammation in physicians. Eur. J. Intern. Med. 24:7 (2013), 664–670.
93. Tobaldini, E., Pecis, M., Montano, N., Effects of acute and chronic sleep deprivation on cardiovascular regulation. Arch. Ital. Biol. 152:2–3 (2014), 103–110.
94. Tononi, G., Cirelli, C., Sleep function and synaptic homeostasis. Sleep Med. Rev. 10:1 (2006), 49–62.
95. Trinder, J., Kleiman, J., Carrington, M., Smith, S., Breen, S., Tan, N., Kim, Y., Autonomic activity during human sleep as a function of time and sleep stage. J. Sleep Res. 10:4 (2001), 253–264.
96. Ulfberg, J., Nyström, B., Carter, N., Edling, C., Prevalence of restless legs syndrome among men aged 18–64 years: an association with somatic disease and neuropsychiatric symptoms. Mov. Disord. 16:6 (2001), 1159–1163.
97. Van Den Eeden, S.K., Albers, K.B., Davidson, J.E., Kushida, C.A., Leimpeter, A.D., Nelson, L.M., Popat, R., Tanner, C.M., Bibeau, K., Quesenberry, C.P., Risk of cardiovascular disease associated with a restless legs syndrome diagnosis in a retrospective cohort study from Kaiser Permanente Northern California. Sleep 38:7 (2015), 1009–1015.
98. Vgontzas, A.N., Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 32:4 (2009), 491–497.
99. Vgontzas, A.N., Liao, D., Bixler, E.O., Chrousos, G.P., Vela-Bueno, A., Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 32:4 (2009), 491–497.
100. Vgontzas, A.N., Liao, D., Pejovic, S., Calhoun, S., Karataraki, M., Bixler, E.O., Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes Care 32:11 (2009), 1980–1985.
101. Walters, A.S., Rye, D.B., Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep 32:5 (2009), 589–597.
102. Wang, H., Parker, J.D., Newton, G.E., Floras, J.S., Mak, S., Chiu, K.L., Ruttanaumpawan, P., Tomlinson, G., Bradley, T.D., Influence of obstructive sleep apnea on mortality in patients with heart failure. J. Am. Coll. Cardiol. 49:15 (2007), 1625–1631.
103. Weinstock, T.G., Wang, X., Rueschman, M., Ismail-Beigi, F., Aylor, J., Babineau, D.C., Mehra, R., Redline, S., A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep 35:5 (2012), 617–625B.
104. Zhong, X., Hilton, H.J., Gates, G.J., Jelic, S., Stern, Y., Bartels, M.N., Demeersman, R.E., Basner, R.C., Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J. Appl. Physiol. 98:6 (2005), 2024–2032.
105. Zobeiri, M., Shokoohi, A., Restless leg syndrome in diabetics compared with normal controls. Sleep Disord., 2014, 2014, 871751.